Composition, Methods and Reagents for the Synthesis of a Soluble Form of Human PHEX
Details for Australian Patent Application No. 2004222823 (hide)
International Classifications
Event Publications
11 November 2004 Complete Application Filed
18 November 2004 Application Open to Public Inspection
Published as AU-B-2004222823
30 November 2006 Application Accepted
Published as AU-B-2004222823
25 January 2007 Assignment before Grant
Universite de Montreal The application has been assigned to Enobia Pharma Inc.
1 February 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 19 Dec 2006. Address for service in Australia - Cullen & Co Level 26 239 George Street Brisbane QLD 4000 2005
24 May 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 19 Dec 2006
31 May 2007 Standard Patent Sealed
16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004222822-A factor VIII-polypeptide with factor VIII:C-activity
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser